[HTML][HTML] Therapeutic advances of miRNAs: A preclinical and clinical update

C Chakraborty, AR Sharma, G Sharma… - Journal of advanced …, 2021 - Elsevier
Background miRNAs, a class of small endogenous RNAs, are one of the essential
biopharmaceuticals which are in commercial spans as next-generation medicine in recent …

MicroRNAs in Alzheimer's disease: diagnostic markers or therapeutic agents?

F Angelucci, K Cechova, M Valis, K Kuca… - Frontiers in …, 2019 - frontiersin.org
MicroRNAs (miRNAs) are small non-coding nucleic acids able to post-transcriptionally
regulate gene expression by binding to complementary sequences of target messenger …

MicroRNA-21 is a versatile regulator and potential treatment target in central nervous system disorders

X Bai, Z Bian - Frontiers in molecular neuroscience, 2022 - frontiersin.org
MicroRNAs (miRNAs) are a class of endogenous, non-coding, single-stranded RNAs with a
length of approximately 22 nucleotides that are found in eukaryotes. miRNAs are involved in …

LncRNA BACE1-AS promotes autophagy-mediated neuronal damage through the miR-214-3p/ATG5 signalling axis in Alzheimer's disease

Y Zhou, Y Ge, Q Liu, YX Li, X Chao, JJ Guan, YC Diwu… - Neuroscience, 2021 - Elsevier
Alzheimer's disease (AD) is the most common neurodegenerative disease and is
characterized by progressive memory loss and cognitive dysfunction. Long non-coding …

RETRACTED: Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with …

ZO Serebrovska, TV Serebrovska, VA Kholin… - International Journal of …, 2019 - mdpi.com
Alzheimer's disease (AD) affects not only the central nervous system, but also peripheral
blood cells including neutrophils and platelets, which actively participate in pathogenesis of …

[PDF][PDF] Long noncoding RNA NEAT1 aggravates Aβ-induced neuronal damage by targeting miR-107 in Alzheimer's disease

S Ke, Z Yang, F Yang, X Wang, J Tan… - Yonsei medical …, 2019 - synapse.koreamed.org
Purpose Alzheimer's disease (AD) is the most common neurodegenerative disease, with a
rising prevalence worldwide. Long noncoding RNAs (lncRNAs) have been found to play …

Intranasal administration of miR-146a agomir rescued the pathological process and cognitive impairment in an AD mouse model

H Mai, W Fan, Y Wang, Y Cai, X Li, F Chen… - … Therapy-Nucleic Acids, 2019 - cell.com
Alzheimer's disease (AD) is the most common cause of dementia and cannot be cured. The
etiology and pathogenesis of AD is still not fully understood, the genetics is considered to be …

Insights into role of microRNA in Alzheimer's disease: from contemporary research to bedside perspective

M Bandakinda, A Mishra - International Journal of Biological …, 2023 - Elsevier
One of the most prevalent neurodegenerative disorders is Alzheimer's disease (AD). Despite
the pervasiveness of AD being considerable, the rates of both diagnosis and therapy are …

[HTML][HTML] The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer

C Chakraborty, AR Sharma, G Sharma, BK Sarkar… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Medical practitioners are recommending combination therapy in cancer for its various
advantages. Combination therapy increases the efficacy of treatment due to its synergistic …

[HTML][HTML] A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals' models with mild cognitive impairment or dementia

S Ayari, A Abellard, M Carayol, E Guedj… - Experimental …, 2023 - Elsevier
Purpose To investigate which type, frequency, duration, intensity, and volume of chronic
exercise might more strongly reduce pro-inflammatory cytokines and enhance anti …